A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma-Reference-Cited by-同舟云学术

A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma

Published:2003-02 Issue:1 Volume:13 Page:97-103
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:Melanoma Research

Author:

Mornex F,Thomas L,Mohr P,Hauschild A,Delaunay M M,Lesimple T,Tilgen W,Bui B N,Guillot B,Ulrich J,Bourdin S,Mousseau M,Cupissol D,Bonneterre M E,de Gislain C,Bensadoun R J,Clavel M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference19 articles.

1. Demographics of Brain Metastasis

2. Prognostic factors in metastatic malignant melanoma. The southeastern cancer study group experience

3. Cerebral metastases of cutaneous melanoma

4. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma. Radiation therapy oncology group brain metastases study I and II

5. High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: A comparison with low-dose fraction therapy

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic Strategies for Intra-cranial Metastatic Melanoma - a Meta-analysis and Systematic Review;Journal of Cancer;2024

2. Radiotherapy for melanoma;Die Onkologie;2023-06-27

3. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022;European Journal of Cancer;2022-07

4. Neurological complications of melanoma;Neurological Complications of Systemic Cancer and Antineoplastic Therapy;2022

5. Immunotherapy for intracranial metastatic melanoma;Cochrane Database of Systematic Reviews;2021-04-19